UnitedHealth Group Incorporated (UHG) is the largest health care company in the United States by revenue, operating through two platforms: UnitedHealthcare, which provides health benefits and insurance, and Optum, which delivers health services and technology across pharmacy, analytics, and care delivery. The company employs more than 400,000 people and serves populations across 175 countries. The primary sources for this analysis are UHG’s 2024 Sustainability Report (published July 2025), the 2024 CDP Corporate Questionnaire, and the 2022 Sustainability Report’s Healthy Environment chapter.
UHG structures its sustainability program around four priorities: building a modern, high-performing health system; maintaining a healthy environment; investing in people and culture; and upholding responsible business practices. The 2024 Sustainability Report marks a significant disclosure step, with two SBTi-validated near-term targets announced for the first time, the first-ever disclosure of financed emissions, and expanded Scope 3 category reporting. Total emissions fell 2.58% in 2024 versus 2023, and renewable electricity sourcing reached 27%.
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/UHG-2024-CDP-Corporate-Questionnaire.pdf
https://www.unitedhealthgroup.com/sustainability/sustainability-at-uhg.html
Sustainability Strategy and Goals
UHG’s ESG governance structure includes direct board-level oversight of environmental issues, with confirmed environmental competency at the Board of Directors level as documented in the 2024 CDP disclosure. Management-level monetary incentives tied to environmental performance attainment are in place across relevant executive roles, and environmental risks and opportunities have affected the company’s financial planning. UHG reports under the GHG Protocol, TCFD, SASB, and the UN SDGs, with third-party limited assurance applied to select Scope 1, 2, and Scope 3 emissions metrics.
UHG formally committed to the SBTi Net-Zero Standard in June 2022, covering Scope 1, 2, and 3 emissions with alignment to the 1.5°C warming limit. The company’s five commercial growth pillars (value-based care, health benefits, health technology, health financial services, and pharmacy services) are structurally linked to sustainability outcomes, creating an alignment between commercial strategy and social impact reporting that is uncommon across the sector.
Net Zero and Carbon Emissions
UHG targets a 60% absolute reduction in Scope 1 and 2 GHG emissions by 2030 against a 2021 baseline, followed by operational net zero (Scope 1 and 2) by 2035. A full value chain net zero target covering all scopes, including financed emissions, is set for 2050, with both near-term targets now SBTi-validated as confirmed in the 2024 Sustainability Report.
- Scope 1 emissions: approximately 119,164 MT CO2e (2023) → 105,782 MT CO2e (2024), an 11.23% year-over-year decrease
- Scope 2 (market-based): approximately 352,265 MT CO2e (2023) → 265,661 MT CO2e (2024), a 24.6% year-over-year decrease driven by renewable energy procurement
- Scope 2 (location-based): 352,988 MT CO2e (2024)
- Total Scope 1+2 (market-based): approximately 471,429 MT CO2e (2023) → 458,770 MT CO2e (2024), a 2.67% reduction
- Scope 3 total: 17,977,601 MT CO2e (2024), representing 97.51% of UHG’s total carbon footprint, essentially flat versus 2023
- Total carbon footprint (Scope 1+2+3): 18,436,371 MT CO2e (2024), a 2.58% decrease versus 2023
- Scope 3 emissions breakdown: purchased goods and services account for approximately 45% of total company footprint, financed/investment emissions approximately 44%, and other measured Scope 3 categories approximately 7%, with Scope 1 at 1% and Scope 2 at 3%
- Scope 3 category coverage: 9 of 15 GHG Protocol Scope 3 categories disclosed in both 2023 and 2024
Water Stewardship
UHG has not yet published a company-wide absolute water withdrawal target with a defined baseline year, though water scarcity is identified as a material climate-related physical risk within the company’s scenario analysis framework. Regionally focused water programs are underway, with the India portfolio operating the most advanced water tracking system.
- 68% of tracked sites hold a Water Use Intensity rating below EPA guidelines (2022)
- India real estate portfolio: 47% of total water usage is treated or recycled water rather than fresh water, following a holistic water-tracking program implemented in 2021
- Philippines: water meters added to five sites in 2022 as part of an expansion of the India water-monitoring model
- Single-facility savings: 392,000+ gallons of water saved at one facility in 2024 through efficiency upgrades
- No company-wide water reduction target or system-level baseline is disclosed as of the 2024 Sustainability Report
Regenerative Agriculture
Regenerative agriculture is not part of UHG’s direct operations or supply chain. The company’s supplier environmental engagement focuses on GHG emissions tracking for Tier 1 suppliers using the EPA USEEIO model. No agricultural sourcing commitments appear in the 2024 Sustainability Report or CDP disclosure, and none are expected given UHG’s managed care and technology business model.
Deforestation and Biodiversity
No formal deforestation or biodiversity targets are published in UHG’s 2024 Sustainability Report or CDP disclosure. UHG’s CDP response indicates biodiversity interdependencies have not been identified as an immediate strategic priority for formal quantitative assessment. The company’s digital-first strategy drives large-scale paper elimination as its primary physical material reduction channel.
- 4.3 billion pieces of paper eliminated since 2022 through digital member communications, e-claims, and digital health records
- 1 billion pieces of paper saved in 2022 alone, including 24 million envelopes eliminated through an automated invoice-detection system
- 91 types of member and provider transactions digitized or enhanced in 2022, reducing certain claims reimbursement timelines from 10 days to 24 hours
- No time-bound deforestation, biodiversity, or nature-based targets published as of the 2024 Sustainability Report
Packaging and Circular Economy
UHG’s circular economy impact is delivered through digital transformation and pharmacy operations innovation rather than traditional packaging sustainability programs. Physical packaging reduction is concentrated in prescription drug fulfillment, where process redesign has generated material reductions in plastic and cooling materials. Formal packaging sustainability targets, system-level recycling rate targets, and landfill diversion metrics by weight are not published in the 2024 report.
- Prescription pack size conversion: approximately 546,000 fewer plastic bottles used in 2022 by shifting prescriptions to larger pack sizes
- Insulated mailer adoption: 489,000 unnecessary coolers eliminated in 2022, with 1.2 million gel packs eliminated cumulatively
- Envelope elimination: more than a 90% reduction in envelope volume via automated invoice detection, projected to save 35 million envelopes per year
- Electronics recycling: 1.7 million lbs of waste diverted through recycling of laptops and PCs (2022)
- Waste pilots: zero-landfill project established at two 150-bed hospitals in Brazil; eight India sites launched on-site composting, diverting 129,254 lbs of organic waste
- No company-wide recycling rate or landfill diversion target published as of 2024
Human Rights and Responsible Sourcing
UHG maps Tier 1 suppliers by GHG emissions using the EPA USEEIO model, covering the majority of Tier 1 with the exception of suppliers added through recent acquisitions. Tier 2 visibility exists on the pharmaceutical supply side, but emissions have not yet been measured for Tier 2. The CDP Supply Chain program is used to request climate disclosures from major suppliers.
- CDP Supply Chain pilot launched in 2022: 83% overall response rate from invited suppliers; 81% of responding suppliers reported emissions-related goals
- 2023 expansion: suppliers representing 80–85% of 2021 baseline supply chain emissions were requested to complete CDP Climate Change Assessments
- Tier 1 coverage: majority of Tier 1 suppliers mapped using EPA USEEIO methodology; suppliers added via acquisitions not yet fully mapped
- No Scope 3 supplier SBTi engagement target with a defined coverage percentage has been published as of the 2024 report
Nutrition and Health
Health access and affordability are the foundation of UHG’s social sustainability mission, with scale-level outcomes across preventive care, chronic disease management, and medication affordability. Preventing disease and improving health outcomes structurally reduces energy, waste, and water-intensive hospital care, linking the health access mission directly to the environmental footprint.
- Gaps in care closed since 2021: 575 million total, including 44 million cancer screenings and 12 million adult immunizations
- Patients in value-based care: 4.7 million, with 70% of enrolled diabetes patients achieving controlled A1c levels
- Home visits (2024): 16 million, delivering preventive and follow-up care directly to patients
- Rides to medical appointments (2024): 3.8 million
- Specialty drug consumer savings delivered through pharmacy services: $2.5 billion
- Target: 85% preventive care utilization across the UHG member population by 2030
Community and Social Impact
UHG’s community health impact is embedded in its care delivery and health equity commitments, with 30 UnitedHealthcare plans receiving NCQA Health Equity Accreditation in 2024. The company co-chairs the National Academy of Medicine’s Action Collaborative on Decarbonizing the U.S. Health Sector, a public-private collaborative that addresses the health sector’s environmental impact; the U.S. health care system accounts for 8.5% of U.S. carbon emissions.
- NCQA Health Equity Accreditation: 30 UnitedHealthcare plans accredited in 2024 for addressing barriers to care in underserved communities
- Clean energy investment: $15 million deployed across operations in 2024
- National Academy of Medicine Health Sector Decarbonization Collaborative: UHG CEO serves as co-chair
- Hurricane Ian response (2022): 9 mobile response units stood up within 96 hours in hardest-hit, lowest-resourced communities; clinicians conducted door-to-door care, and mobile pharmacy units were deployed
Governance and Transparency
The UHG Board of Directors holds direct oversight of environmental issues, with confirmed environmental competency and committee-level responsibility documented in the 2024 CDP submission. Management monetary incentives tied to environmental performance attainment are confirmed at the executive level. The company is evaluating voluntary disclosure alignment with IFRS S2 following the absorption of TCFD recommendations by the ISSB.
- Board oversight: Board of Directors with confirmed environmental competency; committee-level ESG responsibilities disclosed in CDP Section 4
- Management incentives: Monetary incentives for environmental target attainment confirmed in CDP Section 4.5
- External frameworks: CDP Supply Chain, TCFD, SASB, GHG Protocol, UN SDGs
- Third-party assurance: Scope 1, 2, and select Scope 3 emissions verified by an external assurance provider
- External asset managers: Subject to environmental requirements as part of UHG’s investment manager selection and ongoing engagement process, consistent with financed emissions disclosure
Technology and Innovation
UHG’s technology-led sustainability approach centers on digital health platforms, AI governance, and renewable energy procurement to drive material, emissions, and operational efficiency gains simultaneously. The digital-first strategy produced the company’s single most-quantified material sustainability outcome: 4.3 billion pieces of paper eliminated since 2022. Renewable energy procurement drove the approximately 24.6% market-based Scope 2 reduction from 2023 to 2024.
- Renewable electricity: 27% of electricity demand met through renewables in 2024, advancing toward the 100% by 2030 target
- Building Management System pilot (2022): deployed across multiple sites, with the potential to reduce energy consumption by up to 20% over previous systems
- Optum Minnesota headquarters: on-site solar panel installation expected to meet approximately 50% of the site’s energy needs upon completion
- EV pilot study: feasibility study initiated for issuing electric vehicles to clinicians conducting home visits, assessing infrastructure needs, procurement, and expansion opportunities
- AI governance: Responsible AI Program expanded and updated in 2024 across clinical analytics, claims processing, and member services
- Virtual Power Purchase Agreements (VPPAs): being actively evaluated as a primary mechanism for renewable energy sourcing given that a significant portion of UHG’s real estate is leased and cannot be retrofitted for on-site generation
Global Partnerships and Advocacy
UHG participates in the CDP Supply Chain program, mapping and engaging Tier 1 suppliers on GHG emissions tracking, with 83% supplier response rates in the pilot year. The company engaged in activities influencing environmental policy and regulation during 2024, as confirmed in its CDP disclosure. UHG’s role as an institutional investor and insurance underwriter gives it portfolio-level influence; the company now applies environmental requirements to external asset managers as part of its investment selection process.
- CDP Supply Chain: Active Tier 1 supplier GHG mapping; 80–85% of baseline supply chain emissions covered in the 2023 CDP outreach cycle
- National Academy of Medicine Collaborative: UHG CEO co-chairs the Action Collaborative on Decarbonizing the U.S. Health Sector
- Environmental policy advocacy: Confirmed engagement in activities influencing environmental law and regulation during 2024
- Financed emissions: First-time disclosure of investment and insurance underwriting portfolio emissions in 2024, using PCAF methodology for asset classes including corporate bonds, loans, equities, and sovereign debt
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/UHG-2024-CDP-Corporate-Questionnaire.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/2022-sustainability-report-Healthy-Environment-chapter.pdf
https://tracenable.com/company/unitedhealth-group/ghg-emissions
Progress vs. Target Tracker
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://tracenable.com/company/unitedhealth-group/ghg-emissions
https://net0tracker.com/corporates.html/United%20Health%20Group/
https://zerotracker.net/companies/unitedhealth-com-0476
Key Sustainability Innovations and Technologies
UHG’s most material sustainability innovation is the scale deployment of digital health infrastructure that simultaneously eliminates physical materials and improves health outcomes. The digital-first strategy has removed 4.3 billion pieces of paper from administrative and clinical workflows since 2022, reducing direct resource consumption and the indirect GHG emissions associated with printing, mailing, and waste management. Provider digital document delivery increased 200% from 2021 to 2022, with over 1.6 million providers enrolled in e-delivery, and approximately 98% of total claims on core platforms were submitted digitally by 2022.
On the energy side, the $15 million clean energy investment in 2024 and the achievement of 27% renewable electricity sourcing signal progress toward the 2030 target, though the pace remains below the approximately 18 percentage points per year needed to close the gap from the current 27%. The Building Management System pilot, where deployed, carries the potential to reduce energy consumption by up to 20% over previous control systems, representing a scalable efficiency mechanism across UHG’s extensive real estate portfolio.
- Digital-first operations: 4.3 billion pieces of paper eliminated since 2022, the company’s most quantified material sustainability achievement
- Renewable electricity: 27% sourced in 2024 (2030 target: 100%); Scope 2 market-based emissions fell approximately 24.6% year-over-year
- Optum Minnesota solar: On-site solar installation expected to meet approximately 50% of that site’s energy needs upon completion
- Building Management System: Potential 20% energy reduction at deployed sites; pilot phase active as of 2022
- Virtual Power Purchase Agreements: Being evaluated as the primary vehicle for renewable electricity sourcing across the leased real estate portfolio
- EV clinical fleet pilot: Feasibility study initiated for electric vehicles for home-visit clinicians, covering infrastructure requirements and expansion pathways
- Pharmacy waste innovation: 546,000 fewer plastic bottles in 2022 via larger prescription pack sizes; 489,000 coolers eliminated via insulated mailers
- Financed emissions tracking: First-time PCAF-based portfolio emissions disclosure in 2024, covering corporate bonds, loans, equities, and sovereign debt
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/2022-sustainability-report-Healthy-Environment-chapter.pdf
https://www.uhccommunityandstate.com/content/articles/inside-the-unitedhealth-group-2024-sustainability-report-measurable-progre
https://www.linkedin.com/posts/conradfarner_our-teams-have-been-working-for-years-on-activity-7351715078942937091-GYQg
Measurable Impacts
UHG’s 2024 environmental performance shows improvement across Scope 1 and Scope 2 metrics, with an 11.23% Scope 1 reduction and a 24.6% market-based Scope 2 reduction year-over-year. The total carbon footprint (Scope 1+2+3) fell 2.58% versus 2023, with Scope 3 flat at 17,977,601 MT CO2e. Scope 3 emissions at 97.51% of total footprint remain the defining challenge; the two largest categories (purchased goods/services and investment emissions) account for approximately 89% of total company GHG output.
Health system impact metrics demonstrate strong momentum, with 575 million care gaps closed since 2021 and 16 million home visits completed in 2024 alone. UHG’s unique structural advantage is that improvements in health access and preventive care delivery directly reduce the energy, waste, and resource intensity of the broader health system, linking health and environmental outcomes in the same operational model.
- Scope 1 emissions: approximately 119,164 MT CO2e (2023) → 105,782 MT CO2e (2024), an 11.23% reduction
- Scope 2 (market-based): approximately 352,265 MT CO2e (2023) → 265,661 MT CO2e (2024), a 24.6% reduction
- Scope 2 (location-based): 352,988 MT CO2e (2024)
- Total Scope 1+2 (market-based): approximately 471,429 MT CO2e (2023) → 458,770 MT CO2e (2024), a 2.67% reduction
- Total Scope 3: 17,977,601 MT CO2e (2024), flat vs. 2023
- Total carbon footprint (Scope 1+2+3): 18,436,371 MT CO2e (2024), a 2.58% decrease
- Renewable electricity sourcing: 27% in 2024, advancing from prior years
- Paper eliminated since 2022: 4.3 billion pieces
- 2022 GHG baseline context: Scope 1+2 increased 4.7% in 2022 due to M&A-driven growth and increased site occupancy post-pandemic
- Patients in value-based care: 4.7 million, with 70% diabetes A1c control rate
- Home visits (2024): 16 million
- Rides to care (2024): 3.8 million
- Specialty drug consumer savings: $2.5 billion
- NCQA Health Equity Accreditation plans: 30
- Cancer screenings since 2021: 44 million
- Adult immunizations since 2021: 12 million
Source
https://tracenable.com/company/unitedhealth-group/ghg-emissions
https://www.uhccommunityandstate.com/content/articles/inside-the-unitedhealth-group-2024-sustainability-report-measurable-progre
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/2022-sustainability-report-Healthy-Environment-chapter.pdf
Challenges and Areas for Improvement
The most critical unresolved challenge is the gap between the current 27% renewable electricity figure and the 100% target by 2030. At current pace, adding approximately 73 percentage points in 4 years requires roughly 18 percentage points of annual progress. The company has not published a detailed delivery mechanism beyond general VPPA evaluation, and a significant portion of its real estate is leased, limiting on-site generation options.
Scope 3 emissions at 17,977,601 MT CO2e are essentially flat year-over-year and represent 97.51% of the total footprint. The two dominant categories (financed/investment emissions at approximately 44% and purchased goods/services at approximately 45% of total footprint) carry no published reduction targets with defined baselines. Financed emissions were disclosed for the first time in 2024, meaning no reduction trajectory is publicly established for the largest share of UHG’s indirect emissions.
- Renewable electricity gap: 27% achieved in 2024 vs. 100% required by 2030; approximately 73 percentage points remaining in 4 years
- Scope 3 stagnation: 17,977,601 MT CO2e in 2024, flat vs. 2023; no reduction target with a baseline published for the two dominant categories
- Financed emissions: First disclosed in 2024 with no quantified reduction target or baseline year attached, covering the approximately 44% of total footprint tied to investment and insurance underwriting activities
- Water and waste gaps: No company-wide water withdrawal target and no system-level waste or recycling rate metrics published as of 2024, representing material reporting gaps versus health sector peers
- Scope 3 category coverage: Only 9 of 15 GHG Protocol Scope 3 categories disclosed in 2024, unchanged from 2023
- Scope 3 supplier engagement: No company-wide SBTi supplier target coverage percentage has been published, and no supplier climate commitment deadline is in place, despite the CDP Supply Chain program being active
- Scope 1 long-term trajectory: Scope 1 emissions increased 659% since 2018, driven by M&A-related business expansion including large acquisitions; 2022 alone saw a 4.7% Scope 1+2 increase due to post-merger integration
- Plastics and biodiversity: No plastics value chain mapping, no biodiversity targets, and no deforestation commitments published as of 2024
Source
https://tracenable.com/company/unitedhealth-group/ghg-emissions
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/UHG-2024-CDP-Corporate-Questionnaire.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/2022-sustainability-report-Healthy-Environment-chapter.pdf
Future Plans and Long-Term Goals
UHG’s 2030 to 2050 commitments require both significant pace acceleration and structural additions in target-setting for Scope 3 categories. The two SBTi-validated near-term targets announced in the 2024 Sustainability Report transition the company from aspirational commitment to science-aligned accountability, though the detailed capital allocation and delivery mechanisms behind the renewable electricity and Scope 3 targets have not been fully published. Reaching operational net zero by 2035 depends on meeting the 2030 60% Scope 1+2 milestone first.
- SBTi near-term target 1: 60% absolute reduction in Scope 1+2 by 2030 vs. 2021 baseline; SBTi-validated
- SBTi near-term target 2: A second SBTi-validated target covering financed/investment emissions as disclosed in the 2024 report; specific metric not yet extracted from publicly available report excerpts
- Operational net zero (Scope 1+2): target year 2035
- 100% renewable electricity sourcing: target year 2030, with VPPA contracts as the primary planned mechanism for the leased real estate portfolio
- Net zero across full value chain: target year 2050, covering all Scope 1, 2, and 3 categories including financed emissions
- Preventive care utilization: 85% across the UHG member population by 2030
- Scope 3 category expansion: Anticipated disclosure of the remaining 6 of 15 GHG Protocol Scope 3 categories in future reporting cycles
- Financed emissions target-setting: Temperature rating targets and power intensity targets for in-scope investment assets were planned from 2023 onward, with net zero glide paths under development
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://www.linkedin.com/posts/conradfarner_our-teams-have-been-working-for-years-on-activity-7351715078942937091-GYQg
https://net0tracker.com/corporates.html/United%20Health%20Group/
https://zerotracker.net/companies/unitedhealth-com-0476
Comparisons to Industry Competitors
UHG’s direct managed care competitors include CVS Health and Elevance Health (formerly Anthem), but verified and comparable quantitative ESG data for those companies was not available from confirmed sources within the scope of this analysis. The comparison below uses AbbVie and Pfizer as health sector reference points for environmental KPIs, using verified published data, while noting that UHG’s managed care and insurance model produces a structurally different emissions and environmental profile than pharmaceutical manufacturers.
UHG’s absolute Scope 1+2 footprint of 458,770 MT CO2e is comparable to AbbVie’s 422,359 MT CO2e despite UHG generating more than five times AbbVie’s annual revenue, which reflects UHG’s services-based model. UHG’s 97.51% Scope 3 dominance, driven by investment and purchased goods emissions, distinguishes it from pharma peers and makes Scope 1+2 benchmarking less analytically meaningful than a comparison of Scope 3 strategy maturity. On that dimension, UHG is significantly earlier-stage than Pfizer, which has formalized approximately 65% supplier SBTi coverage, versus UHG’s absence of any published supplier target percentage.
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://tracenable.com/company/unitedhealth-group/ghg-emissions
https://www.abbvie.com/content/dam/abbvie-com2/pdfs/esg-disclosure-supplement.pdf
https://thesustainableinnovation.com/pfizer-sustainability/
What to Watch: 12 to 18 Month Indicators
Three specific signals will define whether UHG’s sustainability trajectory holds or weakens over the next 12 to 18 months.
Renewable electricity sourcing update for 2025. UHG reported 27% renewable electricity in 2024, against a 100% target by 2030. Reaching that target requires adding approximately 18 percentage points per year from 2025 onward. A 2025 figure below 40% would place the 2030 target in serious jeopardy and signal a need for accelerated VPPA contracting or a revised approach to on-site generation. The company’s own acknowledgment that its leased real estate portfolio limits on-site options makes VPPA execution speed the single most observable indicator of delivery intent.
Financed emissions baseline and reduction target. UHG disclosed financed emissions for the first time in 2024, using PCAF methodology across corporate bonds, loans, equities, and sovereign debt. No quantified reduction target or baseline year is attached to this category, which represents approximately 44% of UHG’s total carbon footprint. The 2025 Sustainability Report will reveal whether UHG publishes a formal financed emissions reduction target aligned with the SBTi Financial Institution Net-Zero Standard. Absence of a target in the 2025 report would signal that the largest portion of UHG’s environmental footprint remains outside formal governance.
Scope 3 supplier SBTi engagement target. Purchased goods and services represent approximately 45% of UHG’s total carbon footprint and showed no material reduction in 2024. Unlike AbbVie (79.1% supplier SBTi coverage target by 2027) and Pfizer (approximately 65% actual coverage in 2024), UHG has not published a supplier science-based target coverage percentage or deadline. A formal supplier SBTi engagement commitment published in the 2025 Sustainability Report would be the clearest signal that UHG has moved beyond measurement toward supply chain decarbonization execution.
Source
https://www.linkedin.com/posts/conradfarner_our-teams-have-been-working-for-years-on-activity-7351715078942937091-GYQg
https://tracenable.com/company/unitedhealth-group/ghg-emissions
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/2022-sustainability-report-Healthy-Environment-chapter.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/UHG-2024-CDP-Corporate-Questionnaire.pdf
UHG’s 2024 Sustainability Report marks a genuine advance in environmental credibility, anchored by two SBTi-validated near-term targets, the first disclosure of financed emissions using PCAF methodology, and expanded Scope 3 category reporting. The 11.23% Scope 1 reduction and approximately 24.6% Scope 2 market-based reduction in 2024 show that operational decarbonization is producing real results, and the digital-first strategy’s elimination of 4.3 billion pieces of paper since 2022 is a legitimate and scalable material impact.
The structural challenge is clear. Scope 3 is 97.51% of UHG’s footprint, and the two dominant categories (financed emissions and purchased goods/services) together represent approximately 89% of total company GHG output, with no published reduction targets attached to either as of the 2024 report. The 2050 net zero goal cannot function as a credible operational plan until UHG attaches time-bound, SBTi-aligned commitments to these categories. The renewable electricity gap (27% vs. 100% by 2030) compounds this risk and requires a significantly accelerated contracting program to remain on schedule.
Three strategic takeaways stand out for practitioners benchmarking or replicating UHG’s approach:
- Align health system performance metrics with environmental metrics from the start. UHG’s strongest sustainability story is the integration of health access outcomes (575 million care gaps closed, 16 million home visits) with environmental outcomes (reduced hospital energy and material intensity per health outcome). This integration is replicable across any health-sector organization and is currently under-leveraged in most managed care and provider ESG programs.
- Treat Scope 3 financed emissions as a governance issue requiring immediate target-setting. For insurance and managed care companies, investment portfolio emissions dwarf operational emissions by a factor of 10 or more. Publishing a PCAF-based first disclosure without a follow-on reduction target leaves the largest emissions category outside formal accountability. Practitioners should require that financed emissions disclosures be paired with SBTi FI-aligned targets within the same reporting cycle, not the next one.
- Do not rely on renewable energy sourcing percentages without publishing the delivery mechanism. UHG’s 27% figure for 2024 and 100% target for 2030 represent a credibility gap unless the company publicly details the pace of VPPA contracting or on-site generation additions. For health sector practitioners, renewable electricity commitments that exceed the current capacity of the leased real estate portfolio require explicit contractual pathways to be analytically credible.
Source
https://www.unitedhealthgroup.com/content/dam/sustainability-report/2024/pdf/UHG%202024%20Sustainibility%20Report.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/UHG-2024-CDP-Corporate-Questionnaire.pdf
https://www.unitedhealthgroup.com/content/dam/UHG/PDF/2024/sustainability/2022-sustainability-report-Healthy-Environment-chapter.pdf
https://tracenable.com/company/unitedhealth-group/ghg-emissions
https://thesustainableinnovation.com/pfizer-sustainability/
https://www.abbvie.com/content/dam/abbvie-com2/pdfs/esg-disclosure-supplement.pdf
